| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2002;40:175.)
© 2002 American Heart Association, Inc.
Rapid Communication |
From the Hypertension Research Laboratories, Ochsner Clinic Foundation, New Orleans, La.
Correspondence to Michel Slama, Research Division, Ochsner Clinic Foundation, New Orleans, LA 70121. E-mail MSlama0508{at}aol.com
In 1979, we first reported occurrence of biventricular hypertrophy in the original normotensive Wistar-Kyoto (WKY) strain obtained from the National Heart, Lung, and Blood Institute, which was derived directly from the Kyoto laboratory of Okamoto. At that time, we recommended that both ventricles be weighted when WKY are studied so that invalid conclusions are not made. Because no paper confirmed these findings for almost 20 years, heart weights were reported in only a few WKY studies, and the cause of this biventricular hypertrophy remained unknown, we re-evaluated this problem in commercially available rats. We, therefore, investigated WKY rats using transthoracic echocardiography to define the congenital heart defect. Up to 28% of commercially available WKY rats demonstrated severe congenital cardiac abnormalities associated with biventricular hypertrophy. Ventricular septal defect with pulmonary regurgitation was the most commonly encountered cardiac defect; other abnormalities included patent ductus arteriosus, and valvular defects. Pathologic and invasive hemodynamic studies confirmed these echocardiographic findings. Because this defect occurs in a large number of WKY rats obtained commercially from 2 different sources, investigators using this strain must carefully measure both ventricular weights to be certain that inappropriate and invalid conclusions are not derived therefrom.
Key Words: rats, inbred WKY hypertrophy ventricular function hypertension, essential echocardiography
This article has been cited by other articles:
![]() |
J. Varagic, E. D. Frohlich, D. Susic, J. Ahn, L. Matavelli, B. Lopez, and J. Diez AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H853 - H858. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Varagic, E. D. Frohlich, J. Diez, D. Susic, J. Ahn, A. Gonzalez, and B. Lopez Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1503 - H1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Slama, J. Ahn, M. Peltier, J. Maizel, D. Chemla, J. Varagic, D. Susic, C. Tribouilloy, and E. D. Frohlich Validation of echocardiographic and Doppler indexes of left ventricular relaxation in adult hypertensive and normotensive rats Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1131 - H1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ahn, J. Varagic, M. Slama, D. Susic, and E. D. Frohlich Cardiac structural and functional responses to salt loading in SHR Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H767 - H772. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Aiello, M. C. Villa-Abrille, E. M. Escudero, E. L. Portiansky, N. G. Perez, M. C. Camilion de Hurtado, and H. E. Cingolani Myocardial hypertrophy of normotensive Wistar-Kyoto rats Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1229 - H1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Slama, J. Ahn, J. Varagic, D. Susic, and E. D. Frohlich Long-term left ventricular echocardiographic follow-up of SHR and WKY rats: effects of hypertension and age Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H181 - H185. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |